NVNO Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	21 804.00
Średni wolumen	131 350
Kapitalizacja rynkowa	67.25M
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $-0.400 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.64
ATR14	$0.0300 (0.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-13	Alavi Hamed	Sell	8 334	Stock Options
2024-03-13	Alavi Hamed	Buy	8 334	Common Stock
2024-03-13	Alavi Hamed	Sell	8 334	Common Stock
2023-12-05	Glynn Craig	Buy	75 000	Stock Options
2023-12-05	Jenusaitis Matthew	Buy	13 856	Stock Options

INSIDER POWER
44.24
Last 98 transactions
Buy: 6 344 915 \| Sell: 2 475 147

Wolumen Korelacja

Długi: -0.12 (neutral)

Krótki: 0.18 (neutral)

Signal:(44.937) Neutral

enVVeno Medical Korelacja

10 Najbardziej pozytywne korelacje
LRMR	0.878
CFLT	0.862
TYRA	0.859
POWL	0.858
MPWR	0.844
SGMO	0.827
VEON	0.825
LBC	0.823
FWRG	0.82
REYN	0.817

10 Najbardziej negatywne korelacje
GRNA	-0.858
SGLY	-0.849
GIPR	-0.84
SGLB	-0.814
GROW	-0.811
ITRM	-0.803
DCRC	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

enVVeno Medical Korelacja - Waluta/Towar

-0.30
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.34
( neutral )

0.47
( neutral )

enVVeno Medical Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
Przychody:	$0
Zysk brutto:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
Przychody:	$0
Zysk brutto:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-12.80

Financial Reports:

No articles found.

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Aktualne aktualizacje dla enVVeno Medical [NVNO]

Upcoming Earnings Alert